High-dose magnesium for severe asthma attacks in the emergency room
This trial compares a higher dose of magnesium given through an IV to the standard dose for treating severe asthma attacks in the emergency room. It aims to see if the higher dose helps patients breathe better faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with asthma
- You are currently having an asthma attack with symptoms like shortness of breath, wheezing, or chest tightness
- Your doctor has decided you need IV magnesium for your asthma attack
- You are not already on a breathing tube at the start of the ER visit
- You do not have kidney disease, heart block, or are pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving magnesium sulfate through an IV helps children with moderate to severe asthma attacks in the emergency department. If your child is between 2 and 17 years old and still has trouble breathing after three puffs of standard asthma medicine, this study may be an option.
This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.
This study tests if magnesium sulfate, given through an IV, helps children with asthma or bronchiolitis breathe easier. It's a simple treatment that might reduce symptoms and hospital stays for kids aged 1 month to 18 years.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.
This trial studies whether giving magnesium helps people who are hospitalized with low magnesium levels. It may help correct low magnesium and improve how patients feel and recover.
Hear when a new Emergency Department trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.